Page 94 - Coronary hemodynamics in acute myocardial infarction - Matthijs Bax

Chapter 5
15. Teiger E, Garot J, Aptecar E, Bosio P, Woscoboinik J, Pernes JM, Gueret P, Kern M, Dubois-Randé JL, Dupouy P. Coronary blood flow reserve and wall motion recovery in patients undergoing angioplasty for myocardial infarction. Eur Heart J. 1999;20:285–292.
16. Mazur W, Bitar JN, Lechin M, Grinstead WC, Khalil AA, Khan MM, Sekili S, Zoghbi WA, Raizner AE, Kleiman NS. Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow. Am Heart J. 1998;136:335–344.
17. Wakatsuki T, Nakamura M, Tsunoda T, Toma H, Degawa T, Oki T, Yamaguchi T. Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction. J Am Coll Cardiol. 2000;35:1835–1841.
18. Beltrame JF, Crea F, Camici P. Advances in coronary microvascular dysfunction. Heart Lung Circ. 2009;18:19–27.
19. van de Hoef T, Nolte F, Delewi R, Henriques JP, Spaan JA, Tijssen JG, Siebes M, Wykrzykowska JJ, Stone GW, Piek JJ. Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (picso): results from the first-in-man prepare picso study. J Interv Cardiol. 2012;25:549–556.
20. Bax M, de Winter RJ, Koch KT, Schotborgh CE, Tijssen JG, Piek JJ. Time course of microvascular resistance of the infarct and noninfarct coronary artery following an anterior wall acute myocardial infarction. Am J Cardiol. 2006;97:1131–1136.
21. The thrombolysis in myocardial infarction (timi) trial. Phase i findings. Timi study group. N Engl J Med. 1985;312:932–936.
22. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344–2351.
23. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102:2031–2037.
24. De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 2004;109:1223–1225.
25. Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, Baan J, Vis MM, Meuwissen M, van Straalen JP, Fischer J, Koch KT, Piek JJ, Tijssen JG, de Winter RJ. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2011;57:29–36.
26. Kern MJ, Bach RG, Mechem CJ, Caracciolo EA, Aguirre FV, Miller LW, Donohue TJ. Variations in normal coronary vasodilatory reserve stratified by artery, gender, heart transplantation and coronary artery disease. J Am Coll Cardiol. 1996;28:1154–1160.
27. Kern MJ, Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NH, Siebes M, Spaan JA; American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. Circulation. 2006;114:1321–1341.
28. Daher E, Dione DP, Heller EN, Holahan J, DeMan P, Shen M, Hu J, Sinusas AJ. Acute ischemic dysfunction alters coronary flow reserve in remote nonischemic regions: potential mechanical etiology identified in an acute canine model. J Nucl Cardiol. 2000;7:112–122.
29. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331:222–227.
30. Stewart RE, Miller DD, Bowers TR, McCullough PA, Ponto RA, Grines CL, O’Neill WW, Juni JE, Safian RD. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction. J Nucl Med. 1997;38:770–777.
92